Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children Ages 7-13

Medtronic plc today announced that the U.S. Food and Drug Administration (FDA) has approved the use of the MiniMed(TM) 670G system in patients with type 1 diabetes seven years of age and older. This newest system by Medtronic features the company’s m https://globenewswire.com/news-release/2018/06/21/1528183/0/en/Medtronic-Receives-FDA-Approval-of-New-Pediatric-Indication-for-the-MiniMed-TM-670G-Hybrid-Closed-Loop-System-in-Children-Ages-7-13.html